INmune Bio, Inc. (INMB) Tops Q2 EPS by 13c
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.50), $0.13 better than the analyst estimate of ($0.63).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.50), $0.13 better than the analyst estimate of ($0.63).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.